Retinitis pigmentosa stem cell therapy trial tops 2019 retina news

The top retina-related stories on Healio.com/OSN in 2019 included trial results, meeting coverage and FDA approvals.
Here are the top five most-read retina articles of the year:
 
Phase 2a study shows improved vision with stem cell therapy for retinitis pigmentosa
Human retinal progenitor cell therapy from ReNeuron Group is showing positive preliminary results in the company’s ongoing phase 1/2a clinical trial involving patients with retinitis pigmentosa. Read more.
 
Protocol V trial results favor observation strategy for DME with good vision
The DRCR.net Protocol V clinical trial

Full Story →